March 2007

Talent Pool

January 2, 2008

Pharma POOL Dr. Lou Barbato Tikvah Names VP, Clinical R&D, and Chief Medical Officer Atlanta-based Tikvah Therapeutics has named Lou Barbato, M.D., as VP, clinical research and development, and chief medical officer. Tikvah acquires, develops, and commercializes novel therapeutics related to the central nervous system. Dr. Barbato is responsible for all U.S. and global preclinical […]

E-Media

January 2, 2008

Thomson Scientific Expands Pharmaceutical Regulatory Intelligence Coverage Thomson Scientific announces that three new country modules, India, Israel, and Turkey, are now available in IDRAC, the global pharmaceutical regulatory intelligence database. IDRAC is recognized by regulatory professionals as a leading authority in global regulatory intelligence. Updated weekly, the database brings together all of the information needed […]

What’s New

January 2, 2008

CommonHealth Celebrates Opening Of Paris Office The move is designed to allow CommonHealth to broaden its offerings to an increasingly global clientele. CommonHealth has opened an office in Paris. The move is designed to allow CommonHealth to broaden its offerings to an increasingly global clientele. The office serves as a hub, continuing to coordinate with […]

On the Calendar

January 2, 2008

March 15-16 Prescription Drug Pricing InterContinental The Barclay, New York PharmaVOICE subscribers are eligible for a $200 discount; register using priority code 656PHVC. For more information, contact Edward Santelices, American Conference Institute, at 212-352-3220, ext. 239, e-mail e.santelices@cicomm.com, or visit americanconference.com. March 18-20 22nd DIA Annual Clinical Data Management Symposium & Exhibition Hilton in the […]

Letter from the Editor

January 2, 2008

Leadership development is a concern for all executive management teams, no matter the size of their company or their business model. It’s vitally important to have processes in place that foster talent development for the next generation of leaders. The subject of this month’s Forum had been on the books, so to speak, for several […]

UpFront

January 2, 2008

Movers & Shakers HBA Honorees Woman of the Year, Honorable Mentor, and Star Volunteer Meryl Zausner, VP and CFO of Novartis Oncology, has been named as 2007 Woman of the Year by The Healthcare Businesswomen’s Association. Ms. Zausner was a founding member of the Novartis Oncology global business unit, established in 2000 with fewer than […]

Raise Your Voice — Letters

January 2, 2008

Site Value I think most agree the PI/coordinator/patient relationship is key to enrollment and most importantly retention. Therefore PROs should be viewed in the context of their value added to each site that agrees to participate in a study as opposed to being viewed as an added value to the study as insurance against pre-established […]

CME: Measuring the Impact

January 2, 2008

By Denise Myshko Outcomes assessment of continuing education can help determine whether there is a change in participants’ knowledge and performance. March 2007 Barbara Winkelman CME LLC Over time, there is going to be a change in how CME is delivered and how outcomes are measured; there will be more collaboration between CME providers. The […]

PharmaTrax

January 2, 2008

Drug Counterfeiting Creates Need for RFID in European Markets The use of radio frequency identification (RFID) by Europe’s pharmaceutical industry continues to be driven by increasing counterfeit products in the market. Such counterfeiting is largely due to deficiencies in the supply chain and the legalized parallel trade in pharmaceuticals between EU member nations. Frost & […]

A New Era in the Science of Aging

January 2, 2008

By Cynthia Borda Older Americans face new and growing challenges in managing chronic diseases, which are now the leading causes of death among people older than the age of 65. Every seven seconds someone in the United States is celebrating a 60th birthday. This trend began Jan. 1, 2006, and will continue for 18 years. […]

Leadership Development: The Next Generation

January 2, 2008

By Taren Grom Life-sciences organizations operate in a complex and challenging environment that includes tighter funding, reimbursement restrictions, longer and more expensive product development cycles, and more regulatory oversight. Whether future leaders are prepared to manage in this complex and evolving environment, according to experts at Spencer Stuart, depends a great deal on the organizations’ […]

Master Plan: The Making of a Successful Publication Strategy

January 2, 2008

By Elisabeth Pena Villarroel Publication planning is an essential part of the drug-development process. The results of the long, labor-intensive years of a clinical trial are announced to the industry and medical professionals through publication in medical journals. Preparing trial results for publication requires early planning to ensure that important scientific data are communicated to […]

PharmaOutlet

January 2, 2008

Overcoming Challenges to the Path to Combination Product Development Combination products have the potential to vastly improve medical care, making treatment more effective and safe, as well as improving compliance for patients. But because of the novelty and complexity of such products, companies face unique challenges in navigating them through regulatory channels and bringing them […]

Global Connections

January 2, 2008

By Taren Grom, Editor Global outsourcing, as it relates to international sponsor/supplier relationships, is constantly changing and growing. Pharmaceutical companies and their partners can gain significant competitive advantages through global outsourcing when sound business practices are applied to the management and care of these relationships. Sally Goostrey The W Group Since every country has different […]

EDC: Crossing the Chasm

January 2, 2008

In the figurative but practical language of Silicon Valley marketing guru Geoffrey Moore, the leading EDC companies have “crossed the chasm” from the fluidity of the early adopter market to the more established needs of the mainstream market. This may be the dream of many an EDC company CEO, but it is not an easy […]

Moving Science Forward — Dr. Russell M. Medford

January 2, 2008

By Kim Ribbink With a pioneering spirit that has led him to tackle emerging fields of science, Russell M. Medford, M.D., Ph.D., is striving to ensure that AtheroGenics, the company he cofounded in 1993, is creating breakthrough medications for chronic inflammation. March 2007 Entrepreneurial spirit is about taking risks and forging new paths, which is […]

For Art’s Sake

January 2, 2008

A Creative Review by the Experts Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Creating good pharmaceutical advertising and marketing requires agencies […]

Managed Markets: Medicare

January 2, 2008

Although Medicare’s Part D prescription drug program has been a success in many ways, legislators are considering tinkering with the program. By Denise Myshko More of America’s seniors have access to prescription drugs than they did two years ago — and at less cost than first predicted. Still, many experts say Medicare’s prescription drug plan, […]

FEEDBACK